Haleon plc (HLN) 은(는) 상장 기업입니다 헬스케어 섹터의 Drug Manufacturers - Specialty & Generic 산업에서 운영. 본사 소재지는 Weybridge, 영국. 현재 CEO는 Brian James McNamara.
HLN 을(를) 보유 IPO 날짜 2022-07-25, 24,561 명의 정규직 직원, 에 상장 NYSE, 시가총액 $43.23B.
Haleon plc is a consumer healthcare company headquartered in Brentford, United Kingdom, engaged in the research, development, manufacture, and distribution of over-the-counter health and wellness products across North America, Europe, the Middle East, Africa, Latin America, and Asia Pacific. The company's extensive portfolio spans therapeutic oral health, pain relief, respiratory health, digestive health, vitamins, minerals, and supplements, featuring globally recognized brands including Panadol, Voltaren, Advil, Sensodyne, Theraflu, Otrivin, Polident, parodontax, and Centrum. Since its incorporation in 2021 and rebranding to Haleon plc in February 2022, the company has positioned itself as a leading player in the consumer healthcare sector.
